Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2016, Article ID 1656450, 14 pages
http://dx.doi.org/10.1155/2016/1656450
Review Article

The Role of Oxidative Stress in Myocardial Ischemia and Reperfusion Injury and Remodeling: Revisited

1School of Chemical and Biotechnology, SASTRA University, Thanjavur 613401, India
2Department of Pharmacology & Therapeutics, College of Medicine & Health Sciences, UAE University, P.O. Box 17666, Al Ain, UAE

Received 7 January 2016; Revised 11 April 2016; Accepted 3 May 2016

Academic Editor: Alessandra Ricelli

Copyright © 2016 Gino A. Kurian et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. Mozaffarian, E. J. Benjamin, A. S. Go et al., “Heart disease and stroke statistics-2015 update : a report from the American Heart Association,” Circulation, vol. 131, no. 4, pp. e29–e39, 2015. View at Publisher · View at Google Scholar · View at Scopus
  2. C. X. C. Santos, N. Anilkumar, M. Zhang, A. C. Brewer, and A. M. Shah, “Redox signaling in cardiac myocytes,” Free Radical Biology and Medicine, vol. 50, no. 7, pp. 777–793, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. M. S. Willis and C. Patterson, “Proteotoxicity and cardiac dysfunction—Alzheimer's disease of the heart?” The New England Journal of Medicine, vol. 368, no. 5, pp. 455–464, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. E. S. Christians and I. J. Benjamin, “Proteostasis and REDOX state in the heart,” American Journal of Physiology—Heart and Circulatory Physiology, vol. 302, no. 1, pp. H24–H37, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. J. Navarro-Yepes, M. Burns, A. Anandhan et al., “Oxidative stress, redox signaling, and autophagy: cell death versus survival,” Antioxidants and Redox Signaling, vol. 21, no. 1, pp. 66–85, 2014. View at Publisher · View at Google Scholar · View at Scopus
  6. R. Ferrari, O. Alfieri, S. Curello et al., “Occurrence of oxidative stress during reperfusion of the human heart,” Circulation, vol. 81, no. 1, pp. 201–211, 1990. View at Publisher · View at Google Scholar · View at Scopus
  7. O. Zitka, S. Skalickova, J. Gumulec et al., “Redox status expressed as GSH:GSSG ratio as a marker for oxidative stress in paediatric tumour patients,” Oncology Letters, vol. 4, no. 6, pp. 1247–1253, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. C. Kupatt, R. Hinkel, J. Horstkotte et al., “Selective retroinfusion of GSH and cariporide attenuates myocardial ischemia-reperfusion injury in a preclinical pig model,” Cardiovascular Research, vol. 61, no. 3, pp. 530–537, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. P. L. Wendell, “Measurement of oxidized glutathione and total glutathione in the perfused rat heart,” Biochemical Journal, vol. 117, no. 4, pp. 661–665, 1970. View at Publisher · View at Google Scholar · View at Scopus
  10. M. A. Aon, S. Cortassa, C. Maack, and B. O'Rourke, “Sequential opening of mitochondrial ion channels as a function of glutathione redox thiol status,” Journal of Biological Chemistry, vol. 282, no. 30, pp. 21889–21900, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. P. Das, K. K. Nutan, S. L. Singla-Pareek, and A. Pareek, “Oxidative environment and redox homeostasis in plants: dissecting out significant contribution of major cellular organelles,” Frontiers in Environmental Science, vol. 2, article 70, 2015. View at Publisher · View at Google Scholar
  12. C. Penna, D. Mancardi, R. Rastaldo, and P. Pagliaro, “Cardioprotection: a radical view: free radicals in pre and postconditioning,” Biochimica et Biophysica Acta (BBA)—Bioenergetics, vol. 1787, no. 7, pp. 781–793, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. H. Wiseman and B. Halliwell, “Damage to DNA by reactive oxygen and nitrogen species: role in inflammatory disease and progression to cancer,” Biochemical Journal, vol. 313, no. 1, pp. 17–29, 1996. View at Publisher · View at Google Scholar · View at Scopus
  14. E. Roche and D. Romero-Alvira, “Role of oxidative stress in gene expression: myocardial and cerebral ischemia, cancer and other diseases,” Medicina Clinica, vol. 104, no. 12, pp. 468–476, 1995. View at Google Scholar · View at Scopus
  15. P. Venditti, P. Masullo, and S. Di Meo, “Effects of myocardial ischemia and reperfusion on mitochondrial function and susceptibility to oxidative stress,” Cellular and Molecular Life Sciences, vol. 58, no. 10, pp. 1528–1537, 2001. View at Publisher · View at Google Scholar · View at Scopus
  16. J. F. Keaney Jr. and J. A. Vita, “Atherosclerosis, oxidative stress, and antioxidant protection in endothelium-derived relaxing factor action,” Progress in Cardiovascular Diseases, vol. 38, no. 2, pp. 129–154, 1995. View at Publisher · View at Google Scholar · View at Scopus
  17. R. A. Thandavarayan, V. V. Giridharan, K. Watanabe, and T. Konishi, “Diabetic cardiomyopathy and oxidative stress: role of antioxidants,” Cardiovascular and Hematological Agents in Medicinal Chemistry, vol. 9, no. 4, pp. 225–230, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. D. F. Stowe and A. K. S. Camara, “Mitochondrial reactive oxygen species production in excitable cells: modulators of mitochondrial and cell function,” Antioxidants & Redox Signaling, vol. 11, no. 6, pp. 1373–1414, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. A. K. S. Camara, E. J. Lesnefsky, and D. F. Stowe, “Potential therapeutic benefits of strategies directed to mitochondria,” Antioxidants and Redox Signaling, vol. 13, no. 3, pp. 279–347, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. C. B. Wolff, “Normal cardiac output, oxygen delivery and oxygen extraction,” Advances in Experimental Medicine and Biology, vol. 599, pp. 169–182, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. B. Gopalakrishnan, K. M. Nash, M. Velayutham, and F. A. Villamena, “Detection of nitric oxide and superoxide radical anion by electron paramagnetic resonance spectroscopy from cells using spin traps,” Journal of Visualized Experiments, no. 66, article e2810, 2012. View at Google Scholar · View at Scopus
  22. S. Raha, G. E. McEachern, A. T. Myint, and B. H. Robinson, “Superoxides from mitochondrial complex III: the role of manganese superoxide dismutase,” Free Radical Biology and Medicine, vol. 29, no. 2, pp. 170–180, 2000. View at Publisher · View at Google Scholar · View at Scopus
  23. E. Ho, K. Karimi Galougahi, C.-C. Liu, R. Bhindi, and G. A. Figtree, “Biological markers of oxidative stress: applications to cardiovascular research and practice,” Redox Biology, vol. 1, no. 1, pp. 483–491, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. C. M. Arroyo, J. H. Kramer, B. F. Dickens, and W. B. Weglicki, “Identification of free radicals in myocardial ischemia/reperfusion by spin trapping with nitrone DMPO,” FEBS Letters, vol. 221, no. 1, pp. 101–104, 1987. View at Publisher · View at Google Scholar · View at Scopus
  25. K. Carvajal, M. El Hafidi, and G. Baños, “Myocardial damage due to ischemia and reperfusion in hypertriglyceridemic and hypertensive rats: participation of free radicals and calcium overload,” Journal of Hypertension, vol. 17, no. 11, pp. 1607–1616, 1999. View at Publisher · View at Google Scholar · View at Scopus
  26. G. A. Kurian and J. Paddikkala, “Administration of aqueous extract of Desmodium gangeticum (L) root protects rat heart against ischemic reperfusion injury induced oxidative stress,” Indian Journal of Experimental Biology, vol. 47, no. 2, pp. 129–135, 2009. View at Google Scholar · View at Scopus
  27. G. A. Kurian, S. Suryanarayanan, A. Raman, and J. Padikkala, “Antioxidant effects of ethyl acetate extract of Desmodium gangeticum root on myocardial ischemia reperfusion injury in rat hearts,” Chinese Medicine, vol. 5, article 3, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. G. A. Kurian and J. Paddikkala, “N-acetylcysteine and magnesium improve biochemical abnormalities associated with myocardial ischaemic reperfusion in South Indian patients undergoing coronary artery bypass grafting: a comparative analysis,” Singapore Medical Journal, vol. 51, no. 5, pp. 381–388, 2010. View at Google Scholar · View at Scopus
  29. F. J. Giordano, “Oxygen, oxidative stress, hypoxia, and heart failure,” The Journal of Clinical Investigation, vol. 115, no. 3, pp. 500–508, 2005. View at Publisher · View at Google Scholar · View at Scopus
  30. B. R. Lucchesi, “Myocardial ischemia, reperfusion and free radical injury,” The American Journal of Cardiology, vol. 65, no. 19, pp. 14–23, 1990. View at Publisher · View at Google Scholar · View at Scopus
  31. C. Tanaka-Esposito, Q. Chen, and E. J. Lesnefsky, “Blockade of electron transport before ischemia protects mitochondria and decreases myocardial injury during reperfusion in aged rat hearts,” Translational Research, vol. 160, no. 3, pp. 207–216, 2012. View at Publisher · View at Google Scholar · View at Scopus
  32. A. K. Gadicherla, D. F. Stowe, W. E. Antholine, M. Yang, and A. K. S. Camara, “Damage to mitochondrial complex i during cardiac ischemia reperfusion injury is reduced indirectly by anti-anginal drug ranolazine,” Biochimica et Biophysica Acta—Bioenergetics, vol. 1817, no. 3, pp. 419–429, 2012. View at Publisher · View at Google Scholar · View at Scopus
  33. G. Paradies, G. Petrosillo, M. Pistolese, and F. M. Ruggiero, “Reactive oxygen species affect mitochondrial electron transport complex I activity through oxidative cardiolipin damage,” Gene, vol. 286, no. 1, pp. 135–141, 2002. View at Publisher · View at Google Scholar · View at Scopus
  34. J. W. Palmer, B. Tandler, and C. L. Hoppel, “Biochemical properties of subsarcolemmal and interfibrillar mitochondria isolated from rat cardiac muscle,” Journal of Biological Chemistry, vol. 252, no. 23, pp. 8731–8739, 1977. View at Google Scholar · View at Scopus
  35. S. A. Banu, S. Ravindran, and G. A. Kurian, “Hydrogen sulfide post-conditioning preserves interfibrillar mitochondria of rat heart during ischemia reperfusion injury,” Cell Stress and Chaperones, 2016. View at Publisher · View at Google Scholar
  36. B. Chance, H. Sies, and A. Boveris, “Hydroperoxide metabolism in mammalian organs,” Physiological Reviews, vol. 59, no. 3, pp. 527–605, 1979. View at Google Scholar · View at Scopus
  37. C. Crochemore, M. Mekki, C. Corbière et al., “Subsarcolemmal and interfibrillar mitochondria display distinct superoxide production profiles,” Free Radical Research, vol. 49, no. 3, pp. 331–337, 2015. View at Publisher · View at Google Scholar · View at Scopus
  38. G. A. Kurian, E. Berenshtein, A. Saada, and M. Chevion, “Rat cardiac mitochondrial sub-populations show distinct features of oxidative phosphorylation during ischemia, reperfusion and ischemic preconditioning,” Cellular Physiology and Biochemistry, vol. 30, no. 1, pp. 83–94, 2012. View at Publisher · View at Google Scholar · View at Scopus
  39. G. A. Kurian, E. Berenshtein, O. Kakhlon, and M. Chevion, “Energy status determines the distinct biochemical and physiological behavior of interfibrillar and sub-sarcolemmal mitochondria,” Biochemical and Biophysical Research Communications, vol. 428, no. 3, pp. 376–382, 2012. View at Publisher · View at Google Scholar · View at Scopus
  40. A. Lejay, F. Fang, R. John et al., “Ischemia reperfusion injury, ischemic conditioning and diabetes mellitus,” Journal of Molecular and Cellular Cardiology, vol. 91, pp. 11–22, 2016. View at Publisher · View at Google Scholar
  41. H. S. Chung, S.-B. Wang, V. Venkatraman, C. I. Murray, and J. E. Van Eyk, “Cysteine oxidative posttranslational modifications: emerging regulation in the cardiovascular system,” Circulation Research, vol. 112, no. 2, pp. 382–392, 2013. View at Publisher · View at Google Scholar · View at Scopus
  42. H. S. Chung, C. I. Murray, V. Venkatraman et al., “Dual labeling biotin switch assay to reduce bias derived from different cysteine subpopulations: a method to maximize s-nitrosylation detection,” Circulation Research, vol. 117, no. 10, pp. 846–857, 2015. View at Publisher · View at Google Scholar · View at Scopus
  43. M. Talkhabi, N. Aghdami, and H. Baharvand, “Human cardiomyocyte generation from pluripotent stem cells: a state-of-art,” Life Sciences, vol. 145, pp. 98–113, 2016. View at Publisher · View at Google Scholar
  44. O. Bergmann, S. Zdunek, A. Felker et al., “Dynamics of cell generation and turnover in the human heart,” Cell, vol. 161, no. 7, pp. 1566–1575, 2015. View at Publisher · View at Google Scholar · View at Scopus
  45. C. Jopling, E. Sleep, M. Raya, M. Martí, A. Raya, and J. C. I. Belmonte, “Zebrafish heart regeneration occurs by cardiomyocyte dedifferentiation and proliferation,” Nature, vol. 464, no. 7288, pp. 606–609, 2010. View at Publisher · View at Google Scholar · View at Scopus
  46. E. R. Porrello, A. I. Mahmoud, E. Simpson et al., “Transient regenerative potential of the neonatal mouse heart,” Science, vol. 331, no. 6020, pp. 1078–1080, 2011. View at Publisher · View at Google Scholar · View at Scopus
  47. O. Bergmann, R. D. Bhardwaj, S. Bernard et al., “Evidence for cardiomyocyte renewal in humans,” Science, vol. 324, no. 5923, pp. 98–102, 2009. View at Publisher · View at Google Scholar · View at Scopus
  48. J.-O. Jo, S.-R. Kim, M.-K. Bae et al., “Thymosin β4 induces the expression of vascular endothelial growth factor (VEGF) in a hypoxia-inducible factor (HIF)-1α-dependent manner,” Biochimica et Biophysica Acta (BBA)—Molecular Cell Research, vol. 1803, no. 11, pp. 1244–1251, 2010. View at Publisher · View at Google Scholar · View at Scopus
  49. T. Yasukawa, E. Tokunaga, H. Ota, H. Sugita, J. A. J. Martyn, and M. Kaneki, “S-nitrosylation-dependent inactivation of Akt/protein kinase B in insulin resistance,” The Journal of Biological Chemistry, vol. 280, no. 9, pp. 7511–7518, 2005. View at Publisher · View at Google Scholar · View at Scopus
  50. E. T. Chouchani, C. Methner, S. M. Nadtochiy et al., “Cardioprotection by S-nitrosation of a cysteine switch on mitochondrial complex I,” Nature Medicine, vol. 19, no. 6, pp. 753–759, 2013. View at Publisher · View at Google Scholar · View at Scopus
  51. H. L. A. Vieira, A.-S. Belzacq, D. Haouzi et al., “The adenine nucleotide translocator: a target of nitric oxide, peroxynitrite, and 4-hydroxynonenal,” Oncogene, vol. 20, no. 32, pp. 4305–4316, 2001. View at Publisher · View at Google Scholar · View at Scopus
  52. J. R. Hom, R. A. Quintanilla, D. L. Hoffman et al., “The permeability transition pore controls cardiac mitochondrial maturation and myocyte differentiation,” Developmental Cell, vol. 21, no. 3, pp. 469–478, 2011. View at Publisher · View at Google Scholar · View at Scopus
  53. N. S. Chandel, “Mitochondria as signaling organelles,” BMC Biology, vol. 12, article 34, 2014. View at Publisher · View at Google Scholar · View at Scopus
  54. L. M. Buja and R. S. Vander Heide, “Pathobiology of ischemic heart disease: past, present and future,” Cardiovascular Pathology, vol. 25, no. 3, pp. 214–220, 2016. View at Publisher · View at Google Scholar
  55. R. Bretón-Romero and S. Lamas, “Hydrogen peroxide signaling in vascular endothelial cells,” Redox Biology, vol. 2, no. 1, pp. 529–534, 2014. View at Publisher · View at Google Scholar · View at Scopus
  56. M. Y. Lee and K. K. Griendling, “Redox signaling, vascular function, and hypertension,” Antioxidants & Redox Signaling, vol. 10, no. 6, pp. 1045–1059, 2008. View at Publisher · View at Google Scholar · View at Scopus
  57. N. R. Madamanchi and M. S. Runge, “Redox signaling in cardiovascular health and disease,” Free Radical Biology and Medicine, vol. 61, pp. 473–501, 2013. View at Publisher · View at Google Scholar · View at Scopus
  58. A. S. Johnston, S. E. Lehnart, and J. R. Burgoyne, “Ca2+ signaling in the myocardium by (redox) regulation of PKA/CaMKII,” Frontiers in Pharmacology, vol. 6, article 166, 2015. View at Google Scholar
  59. Y.-S. Zhang, L. He, B. Liu et al., “A novel pathway of NADPH oxidase/vascular peroxidase 1 in mediating oxidative injury following ischemia-reperfusion,” Basic Research in Cardiology, vol. 107, no. 3, article 266, 2012. View at Publisher · View at Google Scholar · View at Scopus
  60. V. Braunersreuther, F. Montecucco, M. Asrih et al., “Role of NADPH oxidase isoforms NOX1, NOX2 and NOX4 in myocardial ischemia/reperfusion injury,” Journal of Molecular and Cellular Cardiology, vol. 64, pp. 99–107, 2013. View at Google Scholar
  61. I. Novak, “Mitophagy: a complex mechanism of mitochondrial removal,” Antioxidants & Redox Signaling, vol. 17, no. 5, pp. 794–802, 2012. View at Publisher · View at Google Scholar · View at Scopus
  62. G. W. Dorn, R. B. Vega, and D. P. Kelly, “Mitochondrial biogenesis and dynamics in the developing and diseased heart,” Genes & Development, vol. 29, no. 19, pp. 1981–1991, 2015. View at Publisher · View at Google Scholar · View at Scopus
  63. N. S. Rajasekaran, P. Connell, E. S. Christians et al., “Human α B-crystallin mutation causes oxido-reductive stress and protein aggregation cardiomyopathy in mice,” Cell, vol. 130, no. 3, pp. 427–439, 2007. View at Publisher · View at Google Scholar · View at Scopus
  64. A. C. Brewer, S. B. Mustafi, T. V. A. Murray, N. S. Rajasekaran, and I. J. Benjamin, “Reductive stress linked to small HSPs, G6PD, and Nrf2 pathways in heart disease,” Antioxidants and Redox Signaling, vol. 18, no. 9, pp. 1114–1127, 2013. View at Publisher · View at Google Scholar · View at Scopus
  65. X. Zhang, X. Min, C. Li et al., “Involvement of reductive stress in the cardiomyopathy in transgenic mice with cardiac-specific overexpression of heat shock protein 27,” Hypertension, vol. 55, no. 6, pp. 1412–1417, 2010. View at Publisher · View at Google Scholar · View at Scopus
  66. R. Natarajan, F. N. Salloum, B. J. Fisher, R. C. Kukreja, and A. A. Fowler III, “Hypoxia inducible factor-1 activation by prolyl 4-hydroxylase-2 gene silencing attenuates myocardial ischemia reperfusion injury,” Circulation Research, vol. 98, no. 1, pp. 133–140, 2006. View at Publisher · View at Google Scholar · View at Scopus
  67. J. Hu, L. Dong, and C. E. Outten, “The redox environment in the mitochondrial intermembrane space is maintained separately from the cytosol and matrix,” The Journal of Biological Chemistry, vol. 283, no. 43, pp. 29126–29134, 2008. View at Publisher · View at Google Scholar · View at Scopus
  68. P. Korge, G. Calmettes, and J. N. Weiss, “Increased reactive oxygen species production during reductive stress: the roles of mitochondrial glutathione and thioredoxin reductases,” Biochimica et Biophysica Acta, vol. 1847, no. 6-7, pp. 514–525, 2015. View at Publisher · View at Google Scholar · View at Scopus
  69. H. Zhang, P. Limphong, J. Pieper et al., “Glutathione-dependent reductive stress triggers mitochondrial oxidation and cytotoxicity,” The FASEB Journal, vol. 26, no. 4, pp. 1442–1451, 2012. View at Publisher · View at Google Scholar · View at Scopus
  70. M. Narasimhan and N. S. Rajasekaran, “Reductive potential—a savior turns stressor in protein aggregation cardiomyopathy,” Biochimica et Biophysica Acta, vol. 1852, no. 1, pp. 53–60, 2015. View at Publisher · View at Google Scholar · View at Scopus
  71. G. Morciano, C. Giorgi, M. Bonora et al., “Molecular identity of the mitochondrial permeability transition pore and its role in ischemia-reperfusion injury,” Journal of Molecular and Cellular Cardiology, vol. 78, pp. 142–153, 2015. View at Publisher · View at Google Scholar · View at Scopus
  72. X.-H. Gao, S. Qanungo, H. V. Pai et al., “Aging-dependent changes in rat heart mitochondrial glutaredoxins-implications for redox regulation,” Redox Biology, vol. 1, no. 1, pp. 586–598, 2013. View at Publisher · View at Google Scholar · View at Scopus
  73. E. L. Holmuhamedov, A. Oberlin, K. Short, A. Terzic, and A. Jahangir, “Cardiac subsarcolemmal and interfibrillar mitochondria display distinct responsiveness to protection by diazoxide,” PLoS ONE, vol. 7, no. 9, Article ID e44667, 2012. View at Publisher · View at Google Scholar · View at Scopus
  74. S. Fulda, A. M. Gorman, O. Hori, and A. Samali, “Cellular stress responses: cell survival and cell death,” International Journal of Cell Biology, vol. 2010, Article ID 214074, 23 pages, 2010. View at Publisher · View at Google Scholar · View at Scopus
  75. B. Zingarelli, P. W. Hake, M. O'Connor et al., “Differential regulation of activator protein-1 and heat shock factor-1 in myocardial ischemia and reperfusion injury: role of poly(ADP-ribose) polymerase-1,” American Journal of Physiology—Heart and Circulatory Physiology, vol. 286, no. 4, pp. H1408–H1415, 2004. View at Publisher · View at Google Scholar · View at Scopus
  76. M. Chello, P. Mastroroberto, G. Patti, A. D'Ambrosio, G. Di Sciascio, and E. Covino, “Intermittent warm blood cardioplegia induces the expression of heat shock protein-72 by ischemic myocardial preconditioning,” Cardiovascular Surgery, vol. 11, no. 5, pp. 367–374, 2003. View at Publisher · View at Google Scholar · View at Scopus
  77. G.-Q. Zhong, R.-H. Tu, Z.-Y. Zeng et al., “Novel functional role of heat shock protein 90 in protein kinase C-mediated ischemic postconditioning,” Journal of Surgical Research, vol. 189, no. 2, pp. 198–206, 2014. View at Publisher · View at Google Scholar · View at Scopus
  78. D. Lindholm and U. Arumäe, “Cell differentiation: reciprocal regulation of Apaf-1 and the inhibitor of apoptosis proteins,” The Journal of Cell Biology, vol. 167, no. 2, pp. 193–195, 2004. View at Publisher · View at Google Scholar · View at Scopus
  79. J. Jayakumar, K. Suzuki, M. Khan et al., “Gene therapy for myocardial protection: transfection of donor hearts with heat shock protein 70 gene protects cardiac function against ischemia-reperfusion injury,” Circulation, vol. 102, no. 19, supplement 3, pp. III302–III306, 2000. View at Google Scholar · View at Scopus
  80. K. Suzuki, Y. Sawa, Y. Kaneda, H. Ichihara, R. Shirakura, and H. Matsuda, “In vivo gene transfection with heat shock protein 70 enhances myocardial tolerance to ischemia-reperfusion injury in rat,” Journal of Cardiology, vol. 31, no. 3, pp. 187–188, 1998. View at Google Scholar · View at Scopus
  81. J. A. Barbour and N. Turner, “Mitochondrial stress signaling promotes cellular adaptations,” International Journal of Cell Biology, vol. 2014, Article ID 156020, 12 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  82. T. Masuda, S. Muto, G. Fujisawa et al., “Heart angiotensin II-induced cardiomyocyte hypertrophy suppresses coronary angiogenesis and progresses diabetic cardiomyopathy,” American Journal of Physiology—Heart and Circulatory Physiology, vol. 302, no. 9, pp. H1871–H1883, 2012. View at Publisher · View at Google Scholar · View at Scopus
  83. J. Asbun and F. J. Villarreal, “The pathogenesis of myocardial fibrosis in the setting of diabetic cardiomyopathy,” Journal of the American College of Cardiology, vol. 47, no. 4, pp. 693–700, 2006. View at Publisher · View at Google Scholar · View at Scopus
  84. M. Rajesh, P. Mukhopadhyay, S. Bátkai et al., “Xanthine oxidase inhibitor allopurinol attenuates the development of diabetic cardiomyopathy,” Journal of Cellular and Molecular Medicine, vol. 13, no. 8, pp. 2330–2341, 2009. View at Publisher · View at Google Scholar · View at Scopus
  85. M. Rajesh, P. Mukhopadhyay, S. Btkai et al., “Cannabidiol attenuates cardiac dysfunction, oxidative stress, fibrosis, and inflammatory and cell death signaling pathways in diabetic cardiomyopathy,” Journal of the American College of Cardiology, vol. 56, no. 25, pp. 2115–2125, 2010. View at Publisher · View at Google Scholar · View at Scopus
  86. M. Rajesh, S. Bátkai, M. Kechrid et al., “Cannabinoid 1 receptor promotes cardiac dysfunction, oxidative stress, inflammation, and fibrosis in diabetic cardiomyopathy,” Diabetes, vol. 61, no. 3, pp. 716–727, 2012. View at Publisher · View at Google Scholar · View at Scopus
  87. S. Raposeiras-Roubín, C. Barreiro-Pardal, E. Álvarez, and J. R. González Juanatey, “Is glycated hemoglobin an accurate enough predictor of subclinical myocardial injury or a simple precursor of advanced glycation end products?” Journal of the American College of Cardiology, vol. 60, no. 2, pp. 166–167, 2012. View at Publisher · View at Google Scholar · View at Scopus
  88. Z. V. Varga, Z. Giricz, L. Liaudet, G. Haskó, P. Ferdinandy, and P. Pacher, “Interplay of oxidative, nitrosative/nitrative stress, inflammation, cell death and autophagy in diabetic cardiomyopathy,” Biochimica et Biophysica Acta (BBA)—Molecular Basis of Disease, vol. 1852, no. 2, pp. 232–242, 2015. View at Publisher · View at Google Scholar · View at Scopus
  89. Q. Liu, S. Wang, and L. Cai, “Diabetic cardiomyopathy and its mechanisms: role of oxidative stress and damage,” Journal of Diabetes Investigation, vol. 5, no. 6, pp. 623–634, 2014. View at Publisher · View at Google Scholar · View at Scopus
  90. S. Vedantham, D. Thiagarajan, R. Ananthakrishnan et al., “Aldose reductase drives hyperacetylation of EGR-1 in hyperglycemia and consequent upregulation of proinflammatory and prothrombotic signals,” Diabetes, vol. 63, no. 2, pp. 761–774, 2014. View at Publisher · View at Google Scholar · View at Scopus
  91. M. Abdillahi, R. Ananthakrishnan, S. Vedantham et al., “Aldose reductase modulates cardiac glycogen synthase kinase-3β phosphorylation during ischemia-reperfusion,” American Journal of Physiology, vol. 303, no. 3, pp. H297–H308, 2012. View at Publisher · View at Google Scholar · View at Scopus
  92. V. Srinivasan, A. Radha, S. Ann Marie, and R. Ravichandran, “Aldose reductase, oxidative stress and diabetic cardiovascular complications,” Cardiovascular & Hematological Agents in Medicinal Chemistry, vol. 10, no. 3, pp. 234–240, 2012. View at Google Scholar
  93. S. D. Funk, A. Yurdagul Jr., and A. W. Orr, “Hyperglycemia and endothelial dysfunction in atherosclerosis: lessons from type 1 diabetes,” International Journal of Vascular Medicine, vol. 2012, Article ID 569654, 19 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  94. K. Kaiserova, S. Srivastava, J. D. Hoetker et al., “Redox activation of aldose reductase in the ischemic heart,” The Journal of Biological Chemistry, vol. 281, no. 22, pp. 15110–15120, 2006. View at Publisher · View at Google Scholar · View at Scopus
  95. Y. C. Hwang, M. Kaneko, S. Bakr et al., “Central role for aldose reductase pathway in myocardial ischemic injury,” FASEB Journal, vol. 18, no. 11, pp. 1192–1199, 2004. View at Publisher · View at Google Scholar · View at Scopus
  96. Y. C. Hwang, S. Sato, J.-Y. Tsai et al., “Aldose reductase activation is a key component of myocardial response to ischemia,” The FASEB Journal, vol. 16, no. 2, pp. 243–245, 2002. View at Google Scholar · View at Scopus
  97. R. Ananthakrishnan, Q. Li, T. Gomes, A. M. Schmidt, and R. Ramasamy, “Aldose reductase pathway contributes to vulnerability of aging myocardium to ischemic injury,” Experimental Gerontology, vol. 46, no. 9, pp. 762–767, 2011. View at Publisher · View at Google Scholar · View at Scopus
  98. N.-H. Son, R. Ananthakrishnan, S. Yu et al., “Cardiomyocyte aldose reductase causes heart failure and impairs recovery from ischemia,” PLoS ONE, vol. 7, no. 9, Article ID e46549, 2012. View at Publisher · View at Google Scholar · View at Scopus
  99. W. H. Tang, S. Wu, T. M. Wong, S. K. Chung, and S. S. M. Chung, “Polyol pathway mediates iron-induced oxidative injury in ischemic-reperfused rat heart,” Free Radical Biology and Medicine, vol. 45, no. 5, pp. 602–610, 2008. View at Publisher · View at Google Scholar · View at Scopus
  100. K. Shinmura, R. Bolli, S.-Q. Liu et al., “Aldose reductase is an obligatory mediator of the late phase of ischemic preconditioning,” Circulation Research, vol. 91, no. 3, pp. 240–246, 2002. View at Publisher · View at Google Scholar · View at Scopus
  101. W. H. Tang, G. M. Kravtsov, M. Sauert et al., “Polyol pathway impairs the function of SERCA and RyR in ischemic-reperfused rat hearts by increasing oxidative modifications of these proteins,” Journal of Molecular and Cellular Cardiology, vol. 49, no. 1, pp. 58–69, 2010. View at Publisher · View at Google Scholar · View at Scopus
  102. R. Ananthakrishnan, M. Kaneko, Y. C. Hwang et al., “Aldose reductase mediates myocardial ischemia-reperfusion injury in part by opening mitochondrial permeability transition pore,” American Journal of Physiology—Heart and Circulatory Physiology, vol. 296, no. 2, pp. H333–H341, 2009. View at Publisher · View at Google Scholar · View at Scopus
  103. J. James and J. Robbins, “Molecular remodeling of cardiac contractile function,” American Journal of Physiology, vol. 273, no. 5, part 2, pp. H2105–H2118, 1997. View at Google Scholar · View at Scopus
  104. G. K. Savard, N.-H. Areskog, and B. Saltin, “Cardiovascular response to exercise in humans following acclimatization to extreme altitude,” Acta Physiologica Scandinavica, vol. 154, no. 4, pp. 499–509, 1995. View at Publisher · View at Google Scholar · View at Scopus
  105. I. Afanas'ev, “ROS and RNS signaling in heart disorders: could antioxidant treatment be successful?” Oxidative Medicine and Cellular Longevity, vol. 2011, Article ID 293769, 13 pages, 2011. View at Publisher · View at Google Scholar · View at Scopus
  106. M. Ozeki, H. Nagasu, M. Satoh et al., “Reactive oxygen species mediate compensatory glomerular hypertrophy in rat uninephrectomized kidney,” Journal of Physiological Sciences, vol. 59, no. 5, pp. 397–404, 2009. View at Publisher · View at Google Scholar · View at Scopus
  107. S. Givvimani, C. Munjal, R. Gargoum et al., “Hydrogen sulfide mitigates transition from compensatory hypertrophy to heart failure,” Journal of Applied Physiology, vol. 110, no. 4, pp. 1093–1100, 2011. View at Publisher · View at Google Scholar
  108. J. G. Travers, F. A. Kamal, J. Robbins, K. E. Yutzey, and B. C. Blaxall, “Cardiac fibrosis: the fibroblast awakens,” Circulation Research, vol. 118, no. 6, pp. 1021–1040, 2016. View at Publisher · View at Google Scholar
  109. S. Gorressen, M. Stern, A. M. van de Sandt et al., “Circulating NOS3 modulates left ventricular remodeling following reperfused myocardial infarction,” PLoS ONE, vol. 10, no. 4, Article ID e0120961, 2015. View at Publisher · View at Google Scholar · View at Scopus
  110. J. Li, N. Loukili, N. Rosenblatt-Velin et al., “Peroxynitrite is a key mediator of the cardioprotection afforded by ischemic postconditioning in vivo,” PLoS ONE, vol. 8, no. 7, Article ID e70331, 2013. View at Publisher · View at Google Scholar · View at Scopus
  111. C. M. Sag, C. X. C. Santos, and A. M. Shah, “Redox regulation of cardiac hypertrophy,” Journal of Molecular and Cellular Cardiology, vol. 73, pp. 103–111, 2014. View at Publisher · View at Google Scholar · View at Scopus
  112. R. Schulz, M. Kelm, and G. Heusch, “Nitric oxide in myocardial ischemia/reperfusion injury,” Cardiovascular Research, vol. 61, no. 3, pp. 402–413, 2004. View at Publisher · View at Google Scholar · View at Scopus
  113. P. Mukhopadhyay, M. Rajesh, S. Bátkai et al., “Role of superoxide, nitric oxide, and peroxynitrite in doxorubicin-induced cell death in vivo and in vitro,” American Journal of Physiology—Heart and Circulatory Physiology, vol. 296, no. 5, pp. H1466–H1483, 2009. View at Publisher · View at Google Scholar · View at Scopus
  114. Y. Yang, X. Jin, and C. Jiang, “S-glutathionylation of ion channels: insights into the regulation of channel functions, thiol modification crosstalk, and mechanosensing,” Antioxidants & Redox Signaling, vol. 20, no. 6, pp. 937–951, 2014. View at Publisher · View at Google Scholar · View at Scopus
  115. P. Pacher and C. Szabó, “Role of peroxynitrite in the pathogenesis of cardiovascular complications of diabetes,” Current Opinion in Pharmacology, vol. 6, no. 2, pp. 136–141, 2006. View at Publisher · View at Google Scholar · View at Scopus
  116. D. R. Gonzalez, A. Treuer, Q.-A. Sun, J. S. Stamler, and J. M. Hare, “S-nitrosylation of cardiac ion channels,” Journal of Cardiovascular Pharmacology, vol. 54, no. 3, pp. 188–195, 2009. View at Publisher · View at Google Scholar · View at Scopus
  117. N. Koitabashi and D. A. Kass, “Reverse remodeling in heart failure-mechanisms and therapeutic opportunities,” Nature Reviews Cardiology, vol. 9, no. 3, pp. 147–157, 2012. View at Publisher · View at Google Scholar · View at Scopus
  118. V. R. Pell, E. T. Chouchani, M. P. Murphy, P. S. Brookes, and T. Krieg, “Moving forwards by blocking back-flow: the Yin and yang of MI therapy,” Circulation Research, vol. 118, no. 5, pp. 898–906, 2016. View at Publisher · View at Google Scholar
  119. A. O. Oyewole and M. A. Birch-Machin, “Mitochondria-targeted antioxidants,” The FASEB Journal, vol. 29, no. 12, pp. 4766–4771, 2015. View at Publisher · View at Google Scholar
  120. J. W. Walters, D. Amos, K. Ray, and N. Santanam, “Mitochondrial redox status as a target for cardiovascular disease,” Current Opinion in Pharmacology, vol. 27, pp. 50–55, 2016. View at Publisher · View at Google Scholar
  121. A. H. Talasaz, H. Khalili, F. Fahimi et al., “Effects of N-acetylcysteine on the cardiac remodeling biomarkers and major adverse events following acute myocardial infarction: a randomized clinical trial,” American Journal of Cardiovascular Drugs, vol. 14, no. 1, pp. 51–61, 2014. View at Publisher · View at Google Scholar · View at Scopus
  122. J. Tomé-Carneiro, M. Gonzálvez, M. Larrosa et al., “One-year consumption of a grape nutraceutical containing resveratrol improves the inflammatory and fibrinolytic status of patients in primary prevention of cardiovascular disease,” American Journal of Cardiology, vol. 110, no. 3, pp. 356–363, 2012. View at Publisher · View at Google Scholar · View at Scopus
  123. C. Gladine, N. Combe, C. Vaysse et al., “Optimized rapeseed oil enriched with healthy micronutrients: a relevant nutritional approach to prevent cardiovascular diseases. Results of the Optim'Oils randomized intervention trial,” Journal of Nutritional Biochemistry, vol. 24, no. 3, pp. 544–549, 2013. View at Publisher · View at Google Scholar · View at Scopus
  124. J. I. Dower, J. M. Geleijnse, L. Gijsbers, C. Schalkwijk, D. Kromhout, and P. C. Hollman, “Supplementation of the pure flavonoids epicatechin and quercetin affects some biomarkers of endothelial dysfunction and inflammation in (pre)hypertensive adults: a randomized double-blind, placebo-controlled, crossover trial,” Journal of Nutrition, vol. 145, no. 7, pp. 1459–1463, 2015. View at Publisher · View at Google Scholar · View at Scopus
  125. M. Castaño, J. M. González-Santos, J. López et al., “Effect of preoperative oral pravastatin reload in systemic inflammatory response and myocardial damage after coronary artery bypass grafting. A pilot double-blind placebo-controlled study,” Journal of Cardiovascular Surgery, vol. 56, no. 4, pp. 617–629, 2015. View at Google Scholar · View at Scopus
  126. G. A. Kurian, M. Phil, and J. Paddikkala, “Antioxidant status of South Indian patients undergoing coronary artery bypass graft surgery: a role of intra operative magnesium supplementation,” International Journal of Cardiology, vol. 128, no. 1, pp. 139–141, 2008. View at Publisher · View at Google Scholar · View at Scopus
  127. J. S. Petrofsky, M. Laymon, H. Lee et al., “CoQ10 and endothelial function in Asians from Korea compared to Asians born in the United States and US born Caucasians,” Medical Science Monitor, vol. 19, no. 1, pp. 339–346, 2013. View at Publisher · View at Google Scholar · View at Scopus
  128. T. Altaei, “Protective effect of silymarin during coronary artery bypass grafting surgery,” Experimental and Clinical Cardiology, vol. 17, no. 1, pp. 34–38, 2012. View at Google Scholar · View at Scopus
  129. S. Nishioka, T. Yoshioka, A. Nomura et al., “Celiprolol reduces oxidative stress and attenuates left ventricular remodeling induced by hypoxic stress in mice,” Hypertension Research, vol. 36, no. 11, pp. 934–939, 2013. View at Publisher · View at Google Scholar · View at Scopus
  130. Z.-H. Zhao, J. Shan, M.-X. Xiang, G. Xu, G.-S. Fu, and X.-F. Bao, “Influence of fluvastatin on left ventricular remodeling after myocardial infarction in rats,” Zhejiang Da Xue Xue Bao Yi Xue Ban, vol. 34, no. 5, pp. 447–464, 2005. View at Google Scholar · View at Scopus
  131. K. Takeuchi, T. Omura, M. Yoshiyama et al., “Long-acting calcium channel antagonist pranidipine prevents ventricular remodeling after myocardial infarction in rats,” Heart and Vessels, vol. 14, no. 3, pp. 111–119, 1999. View at Publisher · View at Google Scholar · View at Scopus
  132. X. Zhou, L. Zhao, J. Mao, J. Huang, and J. Chen, “Antioxidant effects of hydrogen sulfide on left ventricular remodeling in smoking rats are mediated via PI3K/Akt-dependent activation of Nrf2,” Toxicological Sciences, vol. 144, no. 1, pp. 197–203, 2015. View at Publisher · View at Google Scholar · View at Scopus
  133. D. Bonaduce, M. Petretta, P. Arrichiello et al., “Effects of captopril treatment on left ventricular remodeling and function after anterior myocardial infarction: comparison with digitalis,” Journal of the American College of Cardiology, vol. 19, no. 4, pp. 858–863, 1992. View at Publisher · View at Google Scholar · View at Scopus
  134. B. Rinaldi, M. Donniacuo, L. Sodano et al., “Effects of chronic treatment with the new ultra-long-acting β2 -adrenoceptor agonist indacaterol alone or in combination with the β1 -adrenoceptor blocker metoprolol on cardiac remodelling,” British Journal of Pharmacology, vol. 172, no. 14, pp. 3627–3637, 2015. View at Publisher · View at Google Scholar · View at Scopus
  135. H. Murase, A. Kuno, T. Miki et al., “Inhibition of DPP-4 reduces acute mortality after myocardial infarction with restoration of autophagic response in type 2 diabetic rats,” Cardiovascular Diabetology, vol. 14, no. 1, article 103, 2015. View at Publisher · View at Google Scholar · View at Scopus
  136. T. Silambarasan, J. Manivannan, M. K. Priya, N. Suganya, S. Chatterjee, and B. Raja, “Sinapic acid protects heart against ischemia/reperfusion injury and H9c2 cardiomyoblast cells against oxidative stress,” Biochemical and Biophysical Research Communications, vol. 456, no. 4, pp. 853–859, 2015. View at Publisher · View at Google Scholar · View at Scopus